The objectives of this study are the assessment of the clinical, radiographical and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty (LimaCorporate S.p.A.) used as standard of care over a period of at least 2 years of follow-up and the evaluation of the incidence of any complication.
The focus of this study is the evaluation on clinical, patient-reported and radiographical outcomes of SMR Stemless Reverse Shoulder Arthroplasty. There is a retrospective and prospective study population. The follow up time-points are (as of standard of care and not different for this study): * Baseline * 6 weeks postop * 6 months postop * 12 months postop * 24 months postop
Study Type
OBSERVATIONAL
Enrollment
60
Arthro Medics AG
Basel, Canton of Basel-City, Switzerland
RECRUITINGSubjective Shoulder Value score
Evaluation of the change of the Subjective Shoulder Value score from pre-operative to the last follow-up visit.
Time frame: 5 years
ASES Shoulder Score
Evaluation of the change of the ASES shoulder score from pre-operative to the last follow-up visit.
Time frame: 5 years
Quick-Dash score
Evaluation of the change of the Quick-Dash score from pre-operative to the last follow-up visit.
Time frame: 5 years
VAS pain
Evaluation of the change of the VAS pain score from pre-operative to the last follow-up visit.
Time frame: 5 years
UCLA shoulder score
Evaluation of the change of the UCLA shoulder score from pre-operative to the last follow-up visit.
Time frame: 5 years
Loosening, implant stability, radiolucent lines
Radiographic evaluation of the implant stability as rate and progression of symptomatic radiolucent lines and loosening.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.